Related Experiment Video
Updated: May 16, 2025
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Micro/nanomotors for active inflammatory disease therapy.
Xue Yang1, Lishan Zhang1, Hui Ran1
1NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China. tuyingfeng1@smu.edu.cn.
Micro/nanomotors (MNMs) offer a novel approach to treating inflammatory diseases by utilizing self-propulsion for enhanced tissue penetration and targeted delivery. This technology presents promising advancements beyond traditional nanoparticle therapies for inflammation.
Area of Science:
- Biomedical Engineering
- Immunology
- Materials Science
Background:
- Inflammation is a critical immune response to tissue injury, but its dysregulation drives inflammatory diseases.
- Current anti-inflammatory drugs have limitations, necessitating innovative therapeutic strategies.
- Micro/nanomotors (MNMs) are emerging as promising biomedical tools due to their autonomous movement.
Purpose of the Study:
- To review recent advancements in micro/nanomotor (MNM)-based therapies for inflammatory diseases.
- To highlight the advantages of MNMs over traditional nanoparticles in treating inflammation.
- To discuss future opportunities and challenges for MNM innovation in inflammatory disease treatment.
Main Methods:
- Review of recent scientific literature on micro/nanomotors for inflammatory disease therapy.
- Analysis of MNM properties, including self-propulsion, tissue penetration, and interaction with inflammatory sites.
- Discussion of therapeutic efficacy and potential applications of MNMs in biomedical fields.
Main Results:
- MNMs demonstrate enhanced tissue penetration and retention compared to passive nanoparticles.
- Self-propulsion enables MNMs to actively target and interact with inflammatory lesions.
- MNMs show potential for efficient therapeutic effects in inflammatory disease models.
Conclusions:
- Micro/nanomotors represent a significant advancement in targeted drug delivery for inflammatory conditions.
- Further research and development are needed to overcome obstacles and realize the full potential of MNMs in treating inflammation.
- MNMs offer innovative opportunities for developing next-generation anti-inflammatory therapies.
